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Summary
Background: Immediate and intermediate term results of percutaneous mitral valvo-
tomy (PMV) are comparable to closed surgical commissurotomy (CSC). We aimed at
exploring this relation in the long term.
Methods: Previously, we randomized 40 consecutive patients with moderate to
severe mitral stenosis [deﬁned as mitral valve area (MVA) less than 1.5 cm2] to
undergo either PMV (PMV group = 20 patients) or CSC (CSC group = 20 patients). For
all patients, full echocardiographic assessment was performed before the proce-
dure/operation. Patients assigned to PMV underwent the double balloon technique.
Echocardiographic assessment was done following both procedures before discharge
and repeated 1 and 6 months later. Echocardiographic follow-up was performed,
thereafter, on a yearly basis for up to 15 years, with a mean follow-up period of
99± 12 months.
Results: Immediate echocardiographic results showed no statistically signiﬁcant
difference between the 2 groups regarding the ﬁnal MVA or mean diastolic
gradient across the mitral valve. Two patients dropped out from the CSC
group and one from the PMV group. MVA was 1.8± 0.3 cm2 versus 1.8± 0.4 cm2
(p > 0.05) and mean diastolic pressure gradient across the mitral valve was
7± 4mmHg versus 6.6± 4mmHg (p > 0.05) in the PMV and CSC groups, respectively.
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Mitral restenosis occurred in 5 (26.3%) patients in the PMV group versus 5 (27.8%)
patients in the CSC group (p > 0.05). Kaplan—Meier curves for restenosis-free survival
showed no difference between the 2 groups.
Conclusion: PMV achieves comparable results to CSC both in the short and long term.
e of Cardiology. Published by Elsevier Ireland Ltd. All rights
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restriction (0—4), calciﬁcation (0—4), and subvalvu-
lar affection (0—4), each expressed out of 4. Left
atrial diameter was measured in parasternal long-© 2008 Japanese Colleg
reserved.
ntroduction
uring the past 15 years, percutaneous mitral
alvotomy (PMV) has emerged as the procedure of
hoice in most patients with symptomatic mitral
tenosis [1]. Large series have observed a promis-
ng outcome both in the short and intermediate
erm [2—6], in addition to a low incidence of serious
omplications [7]. Furthermore, in patients with a
itral valve morphology suitable for balloon valvo-
omy, prospective randomized trials comparing PMV
ith surgical mitral commissurotomy (both open
nd closed) have reported similar clinical, echocar-
iographic, and hemodynamic results between the
wo treatment modalities, added to a shorter
eriod of hospitalization and less mortality and
orbidity in patients assigned to PMV [8—11].
oreover, PMV can still be an option for severely
egenerated and deformed valves, as palliative
reatment in elderly patients with high surgical risk
12,13].
Nevertheless, few data exist about long-term
ollow-up results of PMV in comparison to closed
urgical commissurotomy (CSC) [11,14,15]. We
ought to explore long-term (up to 15 years)
ollow-up results of a prospective randomized study
omparing PMV and CSC in a series of patients with
heumatic moderate to severe mitral stenosis.
atients and methods
opulation
reviously, we enrolled 40 consecutive patients
ith moderate to severe mitral stenosis [deﬁned as
itral valve area (MVA) less than 1.5 cm2] admitted
o our center during the period from Septem-
er 1988 to March 1990, suffering from pulmonary
ongestion symptoms. Patients were considered eli-
ible for enrollment if they had no more than grade
/4 mitral regurgitation (MR) and minimal or mild
itral valve calciﬁcation by echocardiography. We
xcluded patients with previous PMV, previous sur-
ical mitral commissurotomy, those with thrombi in
a
a
ahe left atrial cavity, those with history of prior sys-
emic embolization, those with concomitant valve
isease that needed surgical intervention, those
ndicated for coronary artery bypass surgery, and
hose with limited life expectancy due to coexistent
isease (for example, malignancy). Before inclu-
ion, informed consent was obtained from each
atient and the study protocol was reviewed and
pproved by our local institutional human research
ommittee as it conforms to the ethical guidelines
f the 1975 Declaration of Helsinki.
ethods
fter enrollment, patients were randomly assigned
o undergo either PMV (PMV group = 20 patients)
r CSC (CSC group = 20 patients). Assessment of all
atients by trans-thoracic echocardiography was
erformed within 24 h after admission. Doppler
chocardiography was performed using a Hewlett
ackard Sonos 1000 cardiac ultrasound machine
Hewlett Packard, Andover, MA, USA). A 2.5MHz
hased array probe was used to obtain standard
D and Doppler images. Patients were examined in
he left lateral recumbent position using standard
arasternal and apical views. MVA was assessed by
oth planimetery method in the parasternal short
xis view, and pressure halftime (PHT) method in
he apical 4-chamber view. Mean diastolic pres-
ure gradient across the MV was measured from
oppler spectral analysis of diastolic mitral ﬂow
n the apical 4-chamber view. Semi-quantiﬁcation
f MR grade was obtained by color ﬂow mapping
f MR jet using Helmcke classiﬁcation [16]. Scoring
f the mitral valve was done by the Massachusetts
eneral Hospital (MGH) scoring system (total score
xpressed out of 16) [17] that includes scoring val-
es for mitral valve leaﬂet thickness (0—4), mobilitynd short-axis views. Other chamber size was also
ssessed as well as other valve abnormalities.
Patients in atrial ﬁbrillation received oral
nticoagulants for 6 weeks before the proce-
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dure/operation aiming at an international nor-
malized ratio (INR) 2—3, to minimize the risk of
embolization. Oral anticoagulants were stopped for
several days before the procedure/operation until
the INR decreased below 1.5. PMV was performed
by the standard double balloon technique based on
the method described by Al Zaibag et al. [18] and
modiﬁed by Palacios in 1987 [19]. Balloon size was
chosen according to mitral annular diameter as fol-
lows: sum of diameters of the two balloons equals
mitral annular diameter. Right and left heart hemo-
dynamic data were recorded before and after the
procedure. CSC operation was performed through
a left thoracotomy incision. Tubb’s dilator was
opened to a maximum of 2.5 cm in females and
3.5 cm in males.
Patient assessment by trans-thoracic echocar-
diography was repeated 48 h following PMV, and
within 1 week following CSC, to evaluate ﬁnal MVA
(by both planimetery and PHT methods), mean dias-
tolic pressure gradient across the mitral valve, and
the presence and grade of MR, if any. Residual atrial
septal defect was evaluated in patients who under-
went PMV, by pulsed wave Doppler in the subcostal
4-chamber view.
Follow-up
Clinical and echocardiographic follow-up was per-
formed 1 and 6 months following either procedure,
and then annually for up to 15 years. Echocardio-
graphic follow-up was done using the same cardiac
ultrasound machine (Hewlett Packard Sonos 1000,
Hewlett Packard). Evaluation included assessment
of MVA (by both planimetery and PHT methods),
mean diastolic pressure gradient across the mitral
valve, and the presence and grade of MR, if any.
Residual atrial septal defect was evaluated in
patients who underwent PMV.
Deﬁnitions
Procedural/operation success was deﬁned as an
increase of 25% or more of MVA (measured by PHT
method) with a ﬁnal MVA equal to or more than
1.5 cm2. Suboptimal result was deﬁned as ﬁnal MVA
less than 1.5 cm2 and/or less than 25% increase of
MVA (measured by PHT method). Restenosis was
deﬁned as a decrease of 50% ormore of the ﬁnal MVA
(measured by PHT method) obtained immediately
following either procedure.Statistical analysis
All continuous variables were presented as
mean± S.D., if they were normally distributed.
L
P
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ifferences in the normally distributed variables
ere assessed using the t-test and the paired t-test
or dependent variables. Categorical variables
ere described with absolute and relative (per-
entage) frequencies. Pearson 2 and un-paired
-tests were used to compare the distribution of
ategorical and continuous variables, respectively,
etween the two individual study groups. All tests
ere two-sided and a probability value of p < 0.05
as considered statistically signiﬁcant. Finally,
aplan—Meier curves were constructed to depict
urvival free from restenosis in both the PMV
nd CSC groups. Analyses were performed with
PSS version 12.0 statistical package (SPSS Inc.,
hicago, IL, USA).
esults
total of 40 consecutive patients with moderate
o severe mitral stenosis were included in the cur-
ent study. The mean age of the study population
as 29.7± 7 years, 70% (28 patients) being females.
ix patients (15%) were in atrial ﬁbrillation. Table 1
hows baseline clinical characteristics and initial
chocardiographic ﬁndings of the 2 individual study
roups. No statistically signiﬁcant difference was
ound between the two groups concerning any of
he baseline clinical or initial echocardiographic
haracteristics.
mmediate results
able 2 shows the immediate echocardiographic
esults in both groups. No statistically signiﬁcant
ifference was found between the 2 groups regard-
ng the ﬁnal MVA or mean diastolic gradient across
he mitral valve. Suboptimal results occurred in 3
atients in the PMV group, 2 of whom had signif-
cant subvalvular ﬁbrosis and crossed to the other
roup (CSC group) to undergo CSC, however, only 1
f them had an optimal result after surgery. Among
he CSC group, only 1 patient had a suboptimal
esult. New MR developed in 2 patients in both
roups (10%). One patient (5%) in the PMV group
eveloped hemiplegia, and 3 (15%) developed left-
o-right shunt (all had Qp/Qs below 1.4) as assessed
y oxymetery. Among the CSC group, 1 patient (5%)
eveloped wound infection and another (5%) devel-
ped mild pericardial effusion.ong term follow-up
atients in both groups underwent clinical and
chocardiographic follow-up, on a yearly basis, for
p to 15 years, with a mean follow-up period of
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Table 1 Baseline clinical characteristics and initial echocardiographic ﬁndings of the 2 individual study groups
PMV group (N = 20) CSC group (N = 20) p
Age (years) 26± 9 25± 8 n.s.
Females 13(65) 15(75) n.s.
AF 3(15) 3(15) n.s.
NYHA Class n.s.
Class I 1(5) 1(5) n.s.
Class II 15(75) 13(65) n.s.
Class III 4(20) 6(30) n.s.
Class IV 0(0) 0(0) n.s.
MVA by PHT (cm2) 0.9± 0.3 1± 0.2 n.s.
MVA by 2D (cm2) 0.9± 0.4 1.1± 0.3 n.s.
Mean DPG (mmHg) 17 ± 7 15 ± 6 n.s.
MGH score 5.8± 2.1 6± 2.1 n.s.
All continuous variables are presented as mean± S.D., while categorical variables are presented as numbers (percentage). PMV:
percutaneous mitral valvotomy; CSC: closed surgical commissurotomy; AF: atrial ﬁbrillation; NYHA: New York Heart Association;
MVA: mitral valve area; PHT: pressure halftime; 2D: two-dimensional echo; DPG: diastolic pressure gradient; MGH: Massachusetts
General Hospital.
Table 2 Immediate echocardiographic results following the procedure in the 2 individual study groups
PMV group (N = 20) CSC group (N = 20) p
MVA by PHT (cm2) 2 ± 0.05 2.1 ± 0.05 n.s.
MVA by 2D (cm2) 1.8 ± 0.4 1.6 ± 0.4 n.s.
Mean DPG (mmHg) 6 ± 3 6 ± 4 n.s.
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fContinuous variables are presented as mean± S.D., while ca
percutaneous mitral valvotomy; CSC: closed surgical commissu
dimensional echo; DPG: diastolic pressure gradient.
9± 12 months. Two patients dropped out from
he CSC group and 1 from the PMV group. Clin-
cally, all patients were in NYHA class I, except
or the 2 patients with suboptimal results after
MV (1 of them crossed to the CSC group), and
who had a suboptimal result after CSC. In the
ong term, MVA (measured by PHT method) was
.8± 0.3 cm2 in the PMV group versus 1.8± 0.4 cm2
n the CSC group (p > 0.05) (Table 3). Mean dias-
olic pressure gradient across the mitral valve was
± 4mmHg in the PMV group versus 6.6± 4mmHg
n the CSC group (p > 0.05). In 2 patients who devel-
ped new MR following PMV, MR grade decreased
rom 2/4 to 1/4 in 1, and remained 1/4 in the other;
n
c
f
p
Table 3 Long term follow-up data in the 2 individual study
PMV group (N = 19)
MVA by PHT (cm2) 1.8± 0.3
Mean DPG (mmHg) 7± 4
Restenosis 5 (26.3)
New AF 3 (15.8)
Continuous variables are presented as mean± S.D., while categor
percutaneous mitral valvotomy; CSC: closed surgical commissurot
diastolic pressure gradient; AF: atrial ﬁbrillation.ical variables are presented as numbers (percentage). PMV:
my; MVA: mitral valve area; PHT: pressure halftime; 2D: two-
eanwhile, in the CSC group, MR grade decreased
rom 2/4 to 1/4 in 1 patient and disappeared in
nother who initially developed grade 1/4 MR. New
trial ﬁbrillation developed in 3 (15.8%) patients
n the PMV group and in 4 (22.2%) patients in
he CSC group (p > 0.05). Mitral restenosis occurred
n 5 (26.3%) patients in the PMV group versus 5
27.8%) patients in the CSC group (p > 0.05). PMV
as repeated in 2 out of 5 patients with restenosis
ollowing initial PMV procedure. No mortality was
oted during the follow-up period. Kaplan—Meier
urves for restenosis-free survival showed no dif-
erence between the two groups (log-rank = 0.1;
> 0.05) (Fig. 1). Left-to-right shunt disappeared
groups
CSC group (N = 18) p
1.8± 0.4 n.s.
6.6± 4 n.s.
5 (27.8) n.s.
4 (22.2) n.s.
ical variables are presented as numbers (percentage). PMV:
omy; MVA: mitral valve area; PHT: pressure halftime; DPG:
32
Figure 1 Kaplan—Meier curves for restenosis-free sur-
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underwent the double balloon technique. One com-vival showing no difference between the 2 individual
study groups, log rank = 0.1, p > 0.05.
in 2 out of 3 patients who developed the condi-
tion after PMV, and persisted in 1 at 7 years of
follow-up.
Discussion
The results of the current study represent the
long-term follow-up data of a prospective random-
ized study comparing the safety and efﬁcacy of
PMV procedure versus CSC operation for treatment
of patients with moderate to severe rheumatic
mitral stenosis. To our knowledge, it presents the
longest period of follow-up reported to date in
these patients (up to 15 years with a mean± S.D.
of 99± 12 months).
Both procedures achieved a satisfactory MVA
even at long-term follow-up (1.8± 0.3 cm2 in the
PMV group versus 1.8± 0.4 cm2 in the CSC group),
and credibly a similar mean diastolic trans-mitral
pressure gradient (7± 4mmHg in the PMV group
versus 6.6± 4mmHg in the CSC group). Resteno-
sis rates were also comparable between the two
treatment modalities (25% and 27%) at up to 15
years of follow-up, similar to previous observations
[8,11,20—22].
One interesting ﬁnding is the decrease, or even
disappearance of MR at long-term follow-up, in
both patient groups. Commissural splitting is the
chief mechanism by which MVA is increased during
the procedure of PMV [23,24]. The regression of MR
at follow-up might be explained by gradual healing
of over-split commissures or recovery of papillary
muscle function. Similar regression of MR follow-
p
w
n
sO. Rifaie et al.
ng PMV was also reported by Palacios et al. [3].
omparably, another study found satisfactory long-
erm outcome following PMV even in patients with
nilateral commissural calciﬁcation with no signif-
cant difference from those without commissural
alciﬁcation [25].
Despite earlier reports that left-to-right shunt
isappears on follow-up [3,26], we did notice its
ersistence in 1 patient at 7 years of follow-up.
owever, the shunt was small, hemodynamically
nsigniﬁcant, and this patient had MVA of 1.8 cm2
t follow-up.
The appearance of new cases of atrial ﬁbrillation
n both groups at follow-up highlights the impact of
heumatic affection of the heart and its progression
ith time.
Despite the presence of some randomized stud-
es comparing PMV and surgical commissurotomy
8,9,11,20—22], long term follow-up data are
canty. Farhat et al. reported the results of PMV
ersus both open and closed surgical commissuro-
omy at 7-years follow-up. They observed that
MV was as effective as open surgical commis-
urotomy, both being superior to CSC regarding
heir immediate results and long-term follow-
p [11]. However, they reported that in their
SC cohort, successful splitting of both commis-
ures of the mitral valve occurred in only 66%
f their patients. Their immediate hemodynamic
ata revealed an increase in MVA of only 0.7 cm2
versus 1.3 cm2 in the PMV group), as well as
esidual restenosis rate of 27%. Additionally, their
mmediate echocardiographic data supported these
ifferences reporting an increase of MVA from
.9± 0.2 cm2 to 2.1± 0.5 cm2 in the PMV group ver-
us an increase from 0.9± 0.2 cm2 to 1.6± 0.3 cm2
n the CSC group [11]. It seems that their infe-
ior long-term follow-up results of CSC were due to
ower immediate technical success rate and much
igher residual stenosis rate. Our study presents the
ongest follow-up reported to date in this patient
ategory. We observed similar long-term resteno-
is rates between PMV and CSC procedures (26.3%
nd 27.8%, respectively) at an average follow-up
eriod of 8.3± 1 years which compares well with
gures reported in literature both on short [27] and
ntermediate-term follow-up [28]. It is expected
hat the results of PMV will be sustained for longer
eriods of follow-up by extrapolation from CSC
ong-term data [15].
In our study, all patients in the PMV grouparative study previously reported that compared
ith the Inoue technique, the double balloon tech-
ique results in larger MVA and a lesser degree of
evere MR after PMV. However, there were no signif-
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cant differences in event-free survival at long-term
ollow-up [29]. On the other hand, it was previ-
usly observed that open mitral commissurotomy
chieves larger MVA and a greater increase in car-
iac index compared to CSC [30]. Moreover, it was
eported that both the incidence of reoperation as
ell as valve-related morbidity and mortality were
igniﬁcantly lower after open commissurotomy. Yet,
ong-term survival was similar and excellent for
oth [31].
The fact that 2 patients with severe subvalvular
isease in the PMV group crossed to the CSC group
1 of them had suboptimal results even after CSC)
ighlights the importance of subvalvular affection
n determining the outcome after either procedure.
everal reports addressed the issue that subvalvu-
ar involvement predicts poor outcome after PMV
32—34]. In three series, it was associated with
ost-procedural occurrence or worsening of MR
35—37]. It seems that these patients should be
irectly triaged to open surgical mitral valve com-
issurotomy or even mitral valve replacement.
onclusion
MV achieves comparable results to CSC both in the
hort and long term. The achieved good results of
MV are likely to be sustained for up to 15 years of
ollow-up, remaining similar to CSC.
imitations of the study
ur ﬁndings are based on a single center study
ith a relatively small sample size, a fact that
akes it difﬁcult to generalize our results to all
atients with mitral stenosis. Multicenter studies
sing the same protocol and examining a larger
umber of patients are needed. Moreover, all our
atients underwent PMV with the double balloon
echnique, and it is unknown whether our data can
e safely extrapolated to patients undergoing Inoue
MV and patients undergoing percutaneous metallic
alvotomy.
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